Supernus Pharmaceuticals Inc.

Last updated September 27, 2026

Organization details

Legal name
Supernus Pharmaceuticals Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Rockville
Headquarters state / province
Maryland
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SUPN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001356576

Board of directors

Chief executives

Jack A. Khattar · President, CEO
Dates unknown

Director election results

Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Network of Supernus Pharmaceuticals Inc.'s board connections Indivior Pharmaceuticals Inc. Indivior Pharmaceutica... Alpha Cognition Inc. Alpha Cognition Inc. Cognition Therapeutics Inc. Cognition Therapeutics... Disc Medicine Inc. Disc Medicine Inc. Bethany Sensenig Bethany Sensenig Carrolee Barlow Carrolee Barlow Georges Gemayel Georges Gemayel Jack A. Khattar Jack A. Khattar Supernus Pharmaceuticals I...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$10,264,930
20 sales by 7 insiders
Date Insider Transaction Shares Price Value
Nov 2, 2026 Carrolee Barlow Director Other −27,045 — —
Nov 2, 2026 Bhatt Padmanabh P. Officer (Sr. VP of IP, CSO) Other −18,637 — —
Nov 2, 2026 DEC TIMOTHY C Officer (Senior Vice-President & CFO) Other −9,129 — —
Nov 2, 2026 Georges Gemayel Director Other −27,277 — —
Nov 2, 2026 Frederick M. Hudson Director Other −60,413 — —
Nov 2, 2026 Jack A. Khattar Director, Officer (President, CEO) Other −1,258,351 — —
Nov 2, 2026 Mottola Frank Officer (SVP, Chief Tech. Ops. Officer) Other −19,544 — —
Nov 2, 2026 Charles W. Newhall III Director Other −124,119 — —
Nov 2, 2026 Rubin Jonathan Officer (SVP, Chief Medical Officer) Other −13,979 — —
Nov 2, 2026 Jack A. Khattar Director, Officer (President, CEO) Other −958,100 — —
Aug 12, 2026 Bhatt Padmanabh P. Officer (Sr. VP of IP, CSO) Option exercise +2,500 — —
Aug 12, 2026 DEC TIMOTHY C Officer (Senior Vice-President & CFO) Option exercise +1,250 — —
Aug 12, 2026 Jack A. Khattar Director, Officer (President, CEO) Option exercise +29,849 — —
Aug 12, 2026 Mottola Frank Officer (SVP, Chief Tech. Ops. Officer) Option exercise +1,650 — —
Aug 12, 2026 Rubin Jonathan Officer (SVP, Chief Medical Officer) Option exercise +750 — —

Organizations in the same sector, closest in location and size first.

Questions about Supernus Pharmaceuticals Inc.

Who is the CEO of Supernus Pharmaceuticals Inc.?

Jack A. Khattar is Supernus Pharmaceuticals Inc.'s President, CEO.

How many directors are on Supernus Pharmaceuticals Inc.'s board?

Supernus Pharmaceuticals Inc.'s board has 7 directors: Bethany Sensenig, Carrolee Barlow, Charles W. Newhall III, Frederick M. Hudson, Georges Gemayel, Jack A. Khattar and John M. Siebert.

Are Supernus Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, Supernus Pharmaceuticals Inc. insiders made no open-market purchases and sold $10.3 million of shares in 20 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="supernus-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.